Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Germany

Marie Skłodowska-Curie Action · Running

ReWire Technology-driven combinatorial therapy to rewire the spinal cord after injury

Coordinator
Dwi Leibniz-Institut Fur Interaktive Materialien eV, Germany
Runs
1 January 2023 to 31 December 2026
Status
Running
EU funding
€2.7m
Total cost
—
Partners
27 organisations in 9 countries
Type
Marie Skłodowska-Curie Action
Grant agreement
101073374

What the project is doing

In the project's own words, from its summary on CORDIS.

ReWIRE will combine innovative translational neurotechnologies and rehabilitation interventions for the repair and restoration of neurological functions following injury of the spinal cord (SC). The proposed research program will equip next-generation scientists with unique skills to develop disruptive therapeutic solutions for patients with paralysis. Recent technological breakthroughs have triggered a paradigm shift in the conception of therapies aimed to restore function after spinal cord injury (SCI).

Novel drug delivery systems and biomaterial bridges have been engineered to reduce secondary injury and scarring, to stimulate and guide regenerating nerve fibres across the lesion site, and to promote functional reconnection with intact tissue. Additionally, neuromodulation therapies can reactivate spinal circuits below a SCI, allowing people with chronic paralysis to regain voluntary control of walking. In conjunction with rehabilitation, neurological recovery was promoted that persisted without neuromodulation, suggesting a rewiring of the SC as demonstrated in preclinical models.

To bypass an injury, neuromodulation has been linked to brain signals to re-establish cortical control over spinal circuits by employing electrical nerve stimulation and robotic systems. Advances in robotics are significantly augmenting the impact of neurorehabilitation by inducing new natural “wired” connections. The aim of ReWIRE is to leverage all these technical and therapeutic breakthroughs in the framework of multiple PhD projects that will continuously interact to converge toward effective combinatorial treatments for SCI.

ReWIRE will focus on three inter-woven objectives: i) establish an international, interdisciplinary, and intersectoral educational network, ii) build an SCI clinical data platform, and, iii) position Europe at the forefront of therapy for SCI.

Who is involved

OrganisationCityCountryRole
Dwi Leibniz-Institut Fur Interaktive Materialien eVAachenGermanyCoordinator
University of British ColumbiaVancouverCanadaAssociatedpartner
Centre Hospitalier Universitaire VaudoisLausanneSwitzerlandAssociatedpartner
Creoptix AGWadenswilSwitzerlandAssociatedpartner
Ecole Polytechnique Federale De LausanneLausanneSwitzerlandAssociatedpartner
Myoswiss AGZurichSwitzerlandAssociatedpartner
Universitat ZurichZurichSwitzerlandAssociatedpartner
Aachen Proteineers GmbHBaesweilerGermanyAssociatedpartner
Deutsches Zentrum Fur Neurodegenerative Erkrankungen eVBonnGermanyAssociatedpartner
Johannes Gutenberg-Universitat MainzMainzGermanyAssociatedpartner
Leibniz-Institut Fur Polymerforschung Dresden eVDresdenGermanyAssociatedpartner
Rheinisch-Westfaelische Technische Hochschule AachenAachenGermanyAssociatedpartner
Technische Universitat HamburgHamburgGermanyParticipant
Universitaetsklinikum AachenAachenGermanyAssociatedpartner
Commissariat a L Energie Atomique Et Aux Energies AlternativesParisFranceParticipant
Scuola Superiore Di Studi Universitari E Di Perfezionamento S AnnaPisaItalyParticipant
Wearable Robotics S.r.l.PisaItalyParticipant
The University of TokyoTokyoJapanAssociatedpartner
Biosynth BVLelystadNetherlandsParticipant
Biosynth BVLelystadNetherlandsParticipant
Koninklijke Nederlandse Akademie Van Wetenschappen - KnawAmsterdamNetherlandsAssociatedpartner
Onward Medical NVEindhovenNetherlandsParticipant
Technische Universiteit EindhovenEindhovenNetherlandsParticipant
Imperial College of Science Technology and MedicineLondonUnited KingdomAssociatedpartner
King's College LondonLondonUnited KingdomAssociatedpartner
Malvern Panalytical LimitedMalvernUnited KingdomAssociatedpartner
The Regents of the University of CaliforniaOaklandUnited StatesAssociatedpartner

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI